Skip to main content Skip to section navigation Skip to footer

chevron_leftBack to Evommune.com

Check Out the EADV Webinar of Full Phase 2 Data for Oral MRGPRX2 Inhibitor EVO756 in Chronic Inducible Urticaria.

Click Here

About Us
Our Science
Our Pipeline
Join Us
- Our Culture
- Job Openings
Investors & Media

Select Page

Overview
Company Info
News & Events
Stock Data
Financial & Filings
- Financial Results
- SEC Filings
Corporate Governance
Back to Evommune.com

Documents and Charters

Overview

Overview
Company Info
News & Events
Stock Data
Financial & Filings
- Financial Results
- SEC Filings
Corporate Governance

Corporate Governance
Board of Directors
Board Committees
Documents and Charters

Committee Charters

Audit Committee Charter Download

Compensation Committee Charter Download

Nominating and Corporate Governance Committee Charter Download

Science and Technology Committee Charter Download

Governance Documents

Code of Conduct and Business Ethics Download

Corporate Governance Guidelines Download

Company Profile
Contacts
RSS News Feed
Sitemap
Accessibility Statement

About Us

Overview
Leadership
Collaborating
Contact

Our Science

Approach
Disease Focus
Publications & Posters

Our Pipeline

Development Pipeline
MRGPRX2 Antagonist
IL-18bp Fusion Protein
Clinical Trials

Join Us

Our Culture
Job Openings

Investors & Media

Overview
Company Info
News & Events
Stock Data
Financial & Filings
Corporate Governance

© 2026 Evommune, Inc.

Privacy Policy
Terms of Use

Website by 22 Fillmore